Dietary Supplement Recalled for Presence of Banned Ephedra Alkaloid
Kingsway Trading Inc is recalling Xanthium & Siler Combo (Bi Yan Pian) dietary supplements because they contain Ephedrae Herba (ma huang), a banned ephedra alkaloid.
The agency’s classification
FDA (Food): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class I, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death, meeting the criteria for a Severe rating.
Plain-English summary
Kingsway Trading Inc is voluntarily recalling Xanthium & Siler Combo (Bi Yan Pian) dietary supplements. The product is sold in 100-tablet bottles (300mg each) and is being recalled due to the presence of Ephedrae Herba (ma huang), which is a banned ephedra alkaloid.
The affected products include lot # 020115 (Exp 01/2020) and lot # 040113 (Exp 03/2017). The recall involves 100 cases, 100 bottles, and 100 tablets. The products were distributed through Asian herb stores, acupuncture clinics, and Asian supermarkets in Massachusetts, New Jersey, New York, Illinois, Maryland, Florida, Missouri, Texas, Indiana, Georgia, Delaware, Colorado, Virginia, Pennsylvania, Connecticut, Oregon, and Arizona.
Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund or contact the recalling firm for further instructions.
The recalled product
- Product
- Xanthium & Siler Combo (Bi Yan Pian) DIETARY SUPPLEMENT, Net cont: 100 tablets (300mg each), Net Wt. 1.06oz (30g)
- Manufacturer
- Kingsway Trading Inc
- Category
- Drug — Dietary Supplement
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- lot # 020115 Exp 01/2020 lot # 040113 Exp 03/2017
Distribution
Related recalls
Same hazard · banned ingredient
See all →- SevereMusclMasster Recalls Al-Er-G Capsules Containing Banned Ephedra Ingredient
FDA (Food) · 2017-06-07
Other drug recalls
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- ModerateZoladex Goserelin Implant Recalled Due to Temperature Abuse
FDA (Drugs) · 2026-10-07
- ModerateAjanta Pharma Recalls Ranolazine Tablets for Dissolution Failure
FDA (Drugs) · 2026-10-07
Similar recalls
- SevereBeta Labs Recalls Phentylene Dietary Supplement Containing DMAA
FDA (Food) · 2014-09-03
- CriticalFDA Recalls Asia Black 25 Ephedra Extreme Fat Burner for Unapproved Ingredients
FDA (Drugs) · 2016-06-15
- SevereMusclMasster Recalls Al-Er-G Capsules Containing Banned Ephedra Ingredient
FDA (Food) · 2017-06-07
- ModerateLipodrene With 25mg Ephedra Extract recalled for unapproved food additive
FDA (Food) · 2021-06-09
- CriticalOasis Dietary Supplement Capsules Recalled for Unapproved Active Ingredients
FDA (Drugs) · 2016-10-19
- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19